Monash University
MishraThesis.pdf (4.66 MB)

Evaluation of prognostic factors for survival in patients with Hepatocellular carcinoma treated with Transarterial Chemoembolisation

Download (4.66 MB)
posted on 2020-05-21, 00:09 authored by GAURI KAMAL VASENI MISHRA
Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver and the second leading cause of cancer related mortality globally. This is due to the majority of patients presenting at a disease stage not amenable to curative treatments. Transarterial Chemoembolisation (TACE) is the most common treatment for patients with unresectable HCC, however the median survival ranges from 20 to 45 months. Through collaboration with six large Australian tertiary centres and international co-authors this thesis undertakes a comprehensive evaluation of the prognostic factors associated with survival in patients with unresectable HCC undergoing treatment with TACE.


Principal supervisor

Stuart Roberts

Additional supervisor 1

Anouk Dev

Year of Award


Department, School or Centre

Central Clinical School

Campus location



Doctor of Philosophy

Degree Type



Faculty of Medicine, Nursing and Health Sciences